Mechanistic studies of AV370, a potent FGFR3 antagonistic antibody

被引：0
|
作者：
Bai, Ailin [1 ]
Winston, William [1 ]
Meetze, Kristan [1 ]
Kollipara, Sriram [1 ]
Woo, Jin-Kyeung [1 ]
Nhi Vo [1 ]
Kosmatka, Monica [1 ]
Breault, Lyne [1 ]
Weiler, Solly [1 ]
Kabbarah, Omar [1 ]
Boudrow, Andrea [1 ]
Connolly, Kelly [1 ]
DiPrima, Michael [1 ]
Tissire, Hamid [1 ]
Jiang, Jinwei [1 ]
Gyuris, Jeno [1 ]
Weng, Zhigang [1 ]
机构：
[1] AVEO Pharmaceut Inc, Cambridge, MA USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3775
引用
收藏
页数：2
相关论文
共 38 条
  • [1] Structural Studies of the FGFR3 Dimer.
    Li, E.
    Mudumbi, K.
    Eichman, B.
    MOLECULAR BIOLOGY OF THE CELL, 2012, 23
  • [2] Number and brightness studies of the FGFR3 achondroplasia mutant
    Roy, Tanaya
    Hristova, Kalina
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 56A - 56A
  • [3] G370C mutation in the FGFR3 gene in a Japanese patient with thanatophoric dysplasia
    Katsumata, N
    Kuno, T
    Miyazaki, S
    Mikami, S
    Nagashima-Miyokawa, A
    Nimura, A
    Horikawa, R
    Tanaka, T
    ENDOCRINE JOURNAL, 1998, 45 : S171 - S174
  • [4] A bispecific antibody inhibits FGFR3 dimerization and is highly effective in FGFR3-driven tumor models
    Yang, Yan
    Avvaru, Naga Suhasini
    Jiang, Zaoli
    Liu, Nina
    Rosconi, Michael
    Zhang, Bojie
    Li, Yinyin
    Ullman, Erica
    Lin, John Chia-Yang
    Shen, Yang
    Daly, Christopher
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [5] Studies of molecular mechanism of FGFR3 associated pathgenesis in cells
    He, Lijuan
    Li, Edwin
    O'Connor, Shannon
    Placone, Jesse
    Hristova, Kalina
    BIOPHYSICAL JOURNAL, 2007, : 558A - 558A
  • [6] A Tetravalent Bispecific Antibody Selectively Inhibits Diverse FGFR3 Oncogenic Variants
    Yang, Yan
    Suhasini, Avvaru N.
    Jiang, Zaoli
    Liu, Nina
    Rosconi, Michael
    Zhang, Bojie
    Li, Yinyin
    Dudgeon, Drew
    Seong, Changhyun
    Kim, Steven
    Rafique, Ashique
    Huang, Tammy
    Bhosle, Sangram
    Krueger, Pamela
    Ullman, Erica
    Olson, William
    Lin, John C.
    Shen, Yang
    Daly, Christopher
    CANCER RESEARCH, 2024, 84 (13) : 2169 - 2180
  • [7] Generation and characterization of a monoclonal antibody against FGFR3 that protects mice from BoNT/A
    Xiong, Xianghua
    Qiu, Yujin
    Zheng, Jiahao
    Zhou, Ling
    Wang, Qingyang
    Pang, Jinglun
    Zhang, Weicai
    Chen, Huipeng
    Liu, Gang
    Han, Xiaodong
    PROTEIN EXPRESSION AND PURIFICATION, 2024, 213
  • [8] LY3076226, a novel anti-FGFR3 antibody drug conjugate exhibits potent and durable anti-tumor activity in tumor models harboring FGFR3 mutations or fusions
    Surguladze, David
    Pennello, Anthony
    Ren, Xiaodi
    Mack, Tim
    Rigby, Alan
    Balderes, Paul
    Navarro, Elizabeth
    Amaladas, Nelusha
    Eastman, Scott
    Topper, Michael
    Yao, Yung-Mae
    Moxham, Chris
    Plowman, Gregory
    Ludwig, Dale
    CANCER RESEARCH, 2019, 79 (13)
  • [9] Preclinical characterization of LOX-24350, a highly potent and isoform-selective FGFR3 inhibitor
    Ballard, Joshua A.
    Kercher, Timothy
    Abraham, David
    Brecht, Ryan
    Brooks, Nathan A.
    Buckles, Thomas
    Bume, Desta
    Busha, David
    Cedervall, Ernst Peder
    Condroski, Kevin
    Ebata, Kevin
    Gharbi, Severine Isabelle
    Hazlitt, Robert
    Morales, Tony
    Patel, Nisha
    Podoll, Jessica
    Urkalan, Kaveri
    Villalain, Sandra Gomez
    Walls, Shane
    Watson, Faith
    Yang, Peiyi
    Brandhuber, Barbara J.
    Andrews, Steven W.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [10] Tareetine FGFR3 in t(4;14) mutiple myeloma: Pre-clinical studies of PRO-001, a novel anti-FGFR3 neutralizing antibody.
    Trudel, S
    Wei, E
    Li, ZH
    Rom, E
    Chumakov, I
    Singer, Y
    Chen, C
    Reece, D
    Mikhael, J
    Stewart, AK
    Yayon, A
    BLOOD, 2004, 104 (11) : 680A - 680A
1234